International Edition
Latest News
Health

Shandong Researchers Identify TREM2

Researchers at Shandong Provincial Hospital have identified a specific type of immune cell that may prevent the body from clearing endometriosis tissue, according to a study published in Advanced Science. This discovery offers a potential new path for…

Shandong Researchers Identify TREM2

Researchers at Shandong Provincial Hospital have identified a specific type of immune cell that may prevent the body from clearing endometriosis tissue, according to a study published in Advanced Science.

This discovery offers a potential new path for non-hormonal treatment of the condition, which affects an estimated 200 million women of reproductive age worldwide.

Endometriosis occurs when tissue similar to the uterine lining grows outside the uterus, such as on the ovaries or in the pelvic cavity, often causing chronic pain and fertility issues. While the exact cause is unknown, scientists have long suspected the immune system is involved. Rather than eliminating the abnormal cells, certain immune cells appear to facilitate their survival and growth.

The Chinese research team analyzed tissue and peritoneal fluid from women with and without the condition. They identified a distinct group of macrophages—immune cells typically responsible for removing damaged cells—that carry a protein called TREM2 on their surface. These specific macrophages appeared to suppress the activity of T-cells and natural killer cells, which are essential for identifying and destroying unwanted tissue.

When the team disabled the gene for TREM2 in mice with endometriosis, the resulting lesions were significantly smaller than those in mice where the protein remained active. Blocking TREM2 with antibodies yielded similar results, suggesting that this protein is a key factor in the progression of the disease.

Current standard treatments for endometriosis often rely on surgery or hormone therapy, which may not be suitable or effective for every patient. Developing a therapy that targets TREM2 could provide an alternative approach by helping the immune system naturally control the growth of endometriosis lesions.

While the results in animal models are promising, the effectiveness and safety of blocking TREM2 in humans remain to be established. Because this protein is involved in various bodily processes, further research is required to ensure that a targeted treatment would not cause unintended side effects.

Why does the immune system fail to clear endometriosis tissue?
The study suggests that specific macrophages expressing the TREM2 protein actively suppress the immune cells responsible for clearing abnormal tissue. By interfering with T-cell and natural killer cell activity, these macrophages create an environment that allows endometrial-like tissue to survive and grow outside the uterus.

The findings provide a new target for drug development that avoids the use of hormones. However, because the research is currently limited to animal models, clinical trials are necessary to determine if the same mechanism operates in humans and if it is safe to block the TREM2 protein in a clinical setting.

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”